Concepedia

Author

Arpamas Seetasith

IQVIA (United States)ORCID

Also Known As

A Seetasith, A. Seetasith, Arpamas H Seetasith, Arpamas Seetasith

74

Publications

347

Citations

12

H-Index

16

Concepts

All Affiliations

IQVIA (United States)Otsuka (United States)Northwestern UniversityUniversity of South FloridaFood Allergy Research and Education
AS

About

Arpamas Seetasith is an author at IQVIA (United States) specializing in medicine, oncology, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

30

2

Public Health

1

1

18

3

Epidemiology

1

1

18

4

Risk

1

1

18

5

Cancer Therapeutics

1

1

12

Arpamas Seetasith

×

14

Publications

267

Citations

12

H-Index

YearCitations

Assessment and effect of a gap between new-onset epilepsy diagnosis and treatment in the US

Linda Kalilani, Edward Faught, Hyunmi Kim,

Neurology

2019

59

Economic impact of preventing brain metastases with alectinib in ALK-positive non-small cell lung cancer

Chakkarin Burudpakdee, William B. Wong, Arpamas Seetasith,

Lung Cancer

2018

33

The mental health burden of food allergies: Insights from patients and their caregivers from the Food Allergy Research & Education (FARE) Patient Registry

Thomas B. Casale, Christopher Warren, Sachin Gupta,

World Allergy Organization Journal

2024

19

A Database Cohort Study to Assess the Risk of Angioedema Among Patients with Heart Failure Initiating Angiotensin-Converting Enzyme Inhibitors in the USA

Thy P., Arpamas Seetasith, Rossella Belleli,

American Journal of Cardiovascular Drugs

2017

18

Adherence and Persistence to Nusinersen for Spinal Muscular Atrophy: A US Claims-Based Analysis

David Fox, Tu My To, Arpamas Seetasith,

Advances in Therapy

2022

17

The clinical burden of food allergies: Insights from the Food Allergy Research & Education (FARE) Patient Registry

Christopher Warren, R. Gupta, Arpamas Seetasith,

World Allergy Organization Journal

2024

17

A Real-World Study of 30-Day Exacerbation Outcomes in Chronic Obstructive Pulmonary Disease (COPD) Patients Managed with Aerobika OPEP

Chakkarin Burudpakdee, Arpamas Seetasith, Patrick J Dunne,

Pulmonary Therapy

2017

16

The impact of copay assistance on patient out-of-pocket costs and treatment rates with ALK inhibitors

Arpamas Seetasith, William B. Wong, Jenny Tse,

Journal of Medical Economics

2019

16

Patients with allergic asthma have lower risk of severe COVID-19 outcomes than patients with nonallergic asthma

Thomas Murphy, William W. Busse, Cécile Holweg,

BMC Pulmonary Medicine

2022

14

Changes in healthcare resource use and costs associated with early versus delayed initiation of atypical antipsychotic adjunctive treatment in major depressive disorder

Arpamas Seetasith, Mallik Greene, Ann Hartry,

Journal of Medical Economics

2018

13

Page 1